House Energy and Commerce Committee republicans ask HHS inspector general Christi Grimm to assess the adequacy of FDA’s oversight and support of its Office of Laboratory Safety.
A coalition of 18 attorneys general file a Fourth Circuit appellate brief in support of a lower court decision finding that North Carolina “cannot impose unnecessary and burdensome restrictions” to access the abortion drug mifepristone that were rejected by FDA.
House Energy and Commerce Committee republicans ask HHS inspector general Christi Grimm to assess the adequacy of FDA’s oversight and support of its Office of Laboratory Safety.
A coalition of 18 attorneys general file a Fourth Circuit appellate brief in support of a lower court decision finding that North Carolina “cannot impose unnecessary and burdensome restrictions” to access the abortion drug mifepristone that were rejected by FDA.
FDA accepts for review a Lenz Therapeutics NDA for LNZ100 (aceclidine), an eyedrop medication for treating presbyopia.
FDA clears an iRhythm Technologies 510(k) related to prior design changes made to the Zio AT cardiac telemetry device.
